A just transition for antimicrobial resistance: planning for an equitable and sustainable future with antimicrobial resistance

  18 September 2023

Antimicrobial resistance is among the most urgent global health challenges of our time, with an estimated 4·95 million deaths associated with resistant bacteria in 2019. That microbes develop resistance to antimicrobials is accepted as an evolutionary inevitability for their survival, driven by competition between and among micro-organisms in the natural environment. How to reduce the impact of drug resistance in the future is a matter of global concern, considering the consequences that clinically ineffective antimicrobials will have for health care and agricultural systems that have come to rely on these powerful substances. Paradoxically, this reliance, underpinning massive use of antimicrobials, is understood to drive antimicrobial resistance in humans, animals, and the environment. Planning for a future with antimicrobial resistance, and reducing its burden in clinical, social, and economic terms, will require addressing this paradox.

Further reading: The Lancet
Author(s): Sheila Rose Varadan et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed